ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1929

Pernicious Anemia and Vitamin B-12 Deficiency in Autoimmune Disease:  Neglecting the Feet Will Lead You Astray

Michael R. Lovy, Desert Oasis Healthcare, Palm Springs, CA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Anemia, autoantibodies, autoimmune diseases, neurologic involvement and vitamins

  • Tweet
  • Email
  • Print
Session Information

Title: Miscellaneous Rheumatic and Inflammatory Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose:  The occurrence of multiple autoimmune disorders in individual patients is commonly observed.  Rarely, this is explained by recently recognized genetically based autoimmune polyendocrine syndromes.  Pernicious anemia accompanies other autoimmune disorders both in patients with and without these discrete syndromes.  The purpose of this study was to detect possible underlying vitamin B-12 (B-12) deficiency or pernicious anemia in a rheumatology clinic based on a simple neurologic exam of the feet.

Methods:   Patients seen in a rheumatology clinic over a six month period were examined for evidence of peripheral neuropathy.  If typical findings of stocking sensory loss at the ankle level were found a B-12 level was obtained.  If B-12 levels were low anti parietal cell and intrinsic factor antibody titers were obtained.  Methylmalonic acid (MMA) levels were obtained in patients without either antiparietal cell or intrinsic factor antibodies.  Clinical features of antibody positive patients as well as those with B-12 deficiency and elevated MMA levels were reviewed.

Results:  38 patients with-low B-12 levels were positive for antiparietal cell or intrinsic factor antibodies. An additional 10 patients with low B-12 and elevated methylmelanic acid levels were indentified.  Diagnosis among antibody positive patients included:  rheumatoid arthritis 9-including one with vitiligo, one with Grave’s disease, 2 with Hashimoto’s; lupus 5; primary Sjogren’s 3-including one with stiff man syndrome;  primary Raynaud’s 4;  polyarticular CPPD 3; tophaceous gout 3; vasculitis 2;  ankylosing spondylitis 1; and pyoderma gangrenosum 1. Diagnosis among antibody negative patients included osteoporotic fracture 4, osteoarthritis 4, lupus 2, rheumatoid 2, ankylosing spondylitis 2, tophaceous gout 1, CPPD 1.   Among the lupus and Sjogren’s patients there were 2 positive for both SS-A and SS-B, 3 for SS-A, 1 for SS-B, 3 with anticardiolipin antibody, and 3 with false positive VDRL.  Paraproteinemia was present in 3 patients.  Among the 15 male patients, 7 were being treated for hypogonadism.  Four patients had 25-OH vitamin D levels below 10 ng/ml, 9 patients had thyroid disease, 7 had diabetes, and 13 had a positive family history for either diabetes or an autoimmune disease. The MCV level and hemoglobin level was normal in all but 1 patient who drank alcohol excessively.

Conclusion:  Pernicious anemia and B-12 deficiency was observed in a wide spectrum of autoimmune and arthritic diseases, especially SS-A and SS-B positive individuals.  Other components of autoimmune polyendocrine syndrome including diabetes, thyroid disease, male hypogonadism, and low vitamin D levels, suggesting the possibility of celiac disease, occurred frequently in this study group.  Recognition of pernicious anemia should alert the clinician to the possible presence of other components of autoimmune polyendocrine syndrome and vice versa.  Also, B-12 deficiency can cause elevated MCV, foot complaints, constitutional symptoms, neuropathy that could be mistaken as a complication of the underlying disease or its therapy, and is associated with osteoporotic fractures.  A simple 30 second neurologic exam can lead to the diagnosis of this potentially treatable deficiency.


Disclosure:

M. R. Lovy,
None;

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pernicious-anemia-and-vitamin-b-12-deficiency-in-autoimmune-disease-neglecting-the-feet-will-lead-you-astray/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology